Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001213900-25-041084
Filing Date
2025-05-08
Accepted
2025-05-08 16:20:24
Documents
20
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO FORM 10-K ea0241362-10ka2_180life.htm   iXBRL 10-K/A 172768
2 CERTIFICATION ea024136201ex31-5_180life.htm EX-31.5 3259
3 CERTIFICATION ea024136201ex31-6_180life.htm EX-31.6 3220
8 GRAPHIC image_001.jpg GRAPHIC 15449
  Complete submission text file 0001213900-25-041084.txt   627034

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE atnf-20241231.xsd EX-101.SCH 4123
5 XBRL DEFINITION FILE atnf-20241231_def.xml EX-101.DEF 17284
6 XBRL LABEL FILE atnf-20241231_lab.xml EX-101.LAB 4074
7 XBRL PRESENTATION FILE atnf-20241231_pre.xml EX-101.PRE 6281
22 EXTRACTED XBRL INSTANCE DOCUMENT ea0241362-10ka2_180life_htm.xml XML 15780
Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

EIN.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38105 | Film No.: 25926517
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)